Spill resistant formulations containing clays
    2.
    发明授权
    Spill resistant formulations containing clays 失效
    含有粘土的防溢剂配方

    公开(公告)号:US07981435B2

    公开(公告)日:2011-07-19

    申请号:US12779205

    申请日:2010-05-13

    IPC分类号: A61K9/00

    摘要: The invention relates to novel spill resistant formulations comprising either a weak base or a weak acid as the pharmaceutical ingredient, a liquid base, a clay and a water soluble cellulose ether. The clay and cellulose ether allow for a broader pH range into which the pharmaceutically active agent may be dispersed or dissolved, and therefore allows for easier preparation and formulation of the pharmaceutical composition.

    摘要翻译: 本发明涉及包含作为药物成分的弱碱或弱酸,液体碱,粘土和水溶性纤维素醚的新型防溢剂制剂。 粘土和纤维素醚允许药物活性剂可以分散或溶解的更宽的pH范围,因此允许更容易地制备和配制药物组合物。

    Stable loratadine spill resistant formulation
    5.
    发明授权
    Stable loratadine spill resistant formulation 失效
    稳定的氯雷他定耐药制剂

    公开(公告)号:US07758877B2

    公开(公告)日:2010-07-20

    申请号:US11049310

    申请日:2005-02-02

    IPC分类号: A61K31/55 A61K31/473 A61K9/00

    摘要: The present invention provides for a storage stable pharmaceutical liquid suspension for oral administration having a pharmaceutically effective amount of an antihistamine. The storage stable suspension preferably contains loratadine. The present invention further provides a process of preparing the storage stable pharmaceutical liquid suspension as well as a method of treating a mammal with a therapeutically effective amount of loratadine in the stable pharmaceutical liquid suspension.

    摘要翻译: 本发明提供了具有药学有效量的抗组胺剂的用于口服给药的储存稳定的药用液体悬浮液。 储存稳定的悬浮液优选含有氯雷他定。 本发明进一步提供了制备储存稳定的药物液体悬浮液的方法以及在稳定的药物液体悬液中用治疗有效量的氯雷他定治疗哺乳动物的方法。

    Stable loratadine spill resistant formulation
    6.
    发明申请
    Stable loratadine spill resistant formulation 失效
    稳定的氯雷他定耐药制剂

    公开(公告)号:US20050175642A1

    公开(公告)日:2005-08-11

    申请号:US11049310

    申请日:2005-02-02

    摘要: The present invention provides for a storage stable pharmaceutical liquid suspension for oral administration having a pharmaceutically effective amount of an antihistamine. The storage stable suspension preferably contains loratadine. The present invention further provides a process of preparing the storage stable pharmaceutical liquid suspension as well as a method of treating a mammal with a therapeutically effective amount of loratadine in the stable pharmaceutical liquid suspension.

    摘要翻译: 本发明提供了具有药学有效量的抗组胺剂的用于口服给药的储存稳定的药用液体悬浮液。 储存稳定的悬浮液优选含有氯雷他定。 本发明进一步提供了制备储存稳定的药物液体悬浮液的方法以及在稳定的药物液体悬液中用治疗有效量的氯雷他定治疗哺乳动物的方法。

    STABLE LORATADINE SPILL RESISTANT FORMULATION
    10.
    发明申请
    STABLE LORATADINE SPILL RESISTANT FORMULATION 审中-公开
    稳定的洛伐他汀防漏配方

    公开(公告)号:US20100261748A1

    公开(公告)日:2010-10-14

    申请号:US12823230

    申请日:2010-06-25

    IPC分类号: A61K31/435 A61P27/14

    摘要: The present invention provides for a storage stable pharmaceutical liquid suspension for oral administration having a pharmaceutically effective amount of an antihistamine. The storage stable suspension preferably contains loratadine. The present invention further provides a process of preparing the storage stable pharmaceutical liquid suspension as well as a method of treating a mammal with a therapeutically effective amount of loratadine in the stable pharmaceutical liquid suspension.

    摘要翻译: 本发明提供了具有药学有效量的抗组胺剂的用于口服给药的储存稳定的药用液体悬浮液。 储存稳定的悬浮液优选含有氯雷他定。 本发明进一步提供了制备储存稳定的药物液体悬浮液的方法以及在稳定的药物液体悬液中用治疗有效量的氯雷他定治疗哺乳动物的方法。